Studies about the oral bioavailability of mitonafide and 2HCl amonafide, two new cytotoxic molecules
A I Torres Suárez1, M A Camacho Sánchez
1Departamento de Farmacia y Technología Farmacéutica, Facultad de Farmacia, Universidad Complutense de Madrid, España.
Abstract:
A study was done on the factors which could modify the oral bioavailability of two new cytotoxic molecules (mitonafide and 2HCl amonafide) when administered in solid form. From the values of the ionization constants, we can assume that the absorption of these drugs is produced in the first segments of the small intestine. In the course of both molecules through the digestive tract to the site of absorption, we presume that their chemical stability will not be significantly compromised by the influence of pH of the GI tract. The high aqueous solubility of 2HCl amonafide and the rapid dissolution rate of mitonafide at low pH values lead to assume that the previous dissolution of the drugs will not be an essential factor in the absorption of the oral form.
Insights
The oral bioavailability of cytotoxic drugs mitonafide and 2HCl amonafide is likely unaffected by gastrointestinal pH. Drug dissolution is not a critical factor for absorption of these orally administered compounds.
Area of Science:
- Pharmacology
- Drug Delivery
- Medicinal Chemistry
Background:
- Investigating oral bioavailability of novel cytotoxic agents is crucial for effective cancer therapy.
- Mitonafide and 2HCl amonafide are new cytotoxic molecules with potential for oral administration.
- Understanding factors influencing oral absorption is key to optimizing drug efficacy.
Purpose of the Study:
- To evaluate factors modifying the oral bioavailability of mitonafide and 2HCl amonafide in solid form.
- To assess the impact of gastrointestinal pH and dissolution on drug absorption.
- To predict the absorption sites and stability of the cytotoxic molecules within the digestive tract.
Main Methods:
- Analysis of ionization constants to predict drug absorption sites.
- Assessment of chemical stability in relation to gastrointestinal pH.
- Evaluation of drug solubility and dissolution rates at relevant pH values.
Main Results:
- Drug absorption is predicted to occur in the initial segments of the small intestine.
- Gastrointestinal pH is unlikely to significantly compromise the chemical stability of either molecule.
- High aqueous solubility of 2HCl amonafide and rapid dissolution of mitonafide suggest dissolution is not a limiting factor for oral absorption.
Conclusions:
- Mitonafide and 2HCl amonafide exhibit favorable properties for oral administration.
- Gastrointestinal conditions are unlikely to impede the oral bioavailability of these cytotoxic drugs.
- Further development of solid oral dosage forms for mitonafide and 2HCl amonafide is warranted.
